Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Allakos Inc. (ALLK) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Allakos Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1564824.
Total stock buying since 2018: $33,384,178.
Total stock sales since 2018: $277,345,657.
Total stock option exercises since 2018: $662,504.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 87,064 | $87,934 | 0 | $0 |
| 2022 | 4,459,000 | $22,384,180 | 0 | $0 | 0 | $0 |
| 2021 | 0 | $0 | 569,458 | $63,465,317 | 465,198 | $603,606 |
| 2020 | 0 | $0 | 2,434,183 | $180,305,100 | 13,656 | $58,898 |
| 2019 | 0 | $0 | 888,655 | $33,487,306 | 0 | $0 |
| 2018 | 611,111 | $10,999,998 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-06 | 0 | $0 | 87,064 | $87,934 | 0 | $0 |
| 2022-09 | 4,459,000 | $22,384,180 | 0 | $0 | 0 | $0 |
| 2021-09 | 0 | $0 | 4,000 | $432,480 | 4,000 | $2,100 |
| 2021-08 | 0 | $0 | 0 | $0 | 64,148 | $276,670 |
| 2021-06 | 0 | $0 | 69,161 | $6,353,476 | 43,550 | $29,961 |
| 2021-05 | 0 | $0 | 60,000 | $5,860,800 | 60,000 | $41,277 |
| 2021-04 | 0 | $0 | 110,000 | $11,971,000 | 110,000 | $99,427 |
| 2021-03 | 0 | $0 | 326,297 | $38,847,561 | 183,500 | $154,171 |
| 2020-12 | 0 | $0 | 103,415 | $14,667,691 | 13,656 | $58,898 |
| 2020-06 | 0 | $0 | 7,692 | $587,053 | 0 | $0 |
| 2020-05 | 0 | $0 | 2,323,076 | $165,050,356 | 0 | $0 |
| 2019-06 | 0 | $0 | 322,746 | $12,900,386 | 0 | $0 |
| 2019-05 | 0 | $0 | 50,000 | $1,995,084 | 0 | $0 |
| 2019-04 | 0 | $0 | 178,634 | $6,507,199 | 0 | $0 |
| 2019-02 | 0 | $0 | 284,438 | $9,821,100 | 0 | $0 |
| 2019-01 | 0 | $0 | 52,837 | $2,263,537 | 0 | $0 |
| 2018-07 | 611,111 | $10,999,998 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-06-28 | Radford Harlan Baird (Chief Financial Officer) | Sale | 87,064 | 1.01 | 87,934 |
| 2022-09-21 | Walker Paul Edward (Director) | Buy | 3,984,000 | 5.02 | 19,999,680 |
| 2022-09-21 | Janney Daniel (Director) | Buy | 475,000 | 5.02 | 2,384,500 |
| 2021-09-28 | James Steven P (Director) | Sale | 4,000 | 108.12 | 432,480 |
| 2021-09-28 | James Steven P (Director) | Option Ex | 4,000 | .53 | 2,100 |
| 2021-08-31 | Tomasi Adam (President and COO) | Option Ex | 64,148 | 4.31 | 276,670 |
| 2021-06-07 | Tomasi Adam (President and COO) | Sale | 2,487 | 92.03 | 228,878 |
| 2021-06-04 | Tomasi Adam (President and COO) | Sale | 642 | 90.26 | 57,946 |
| 2021-06-04 | Alexander Robert (Chief Executive Officer) | Sale | 23,595 | 89.63 | 2,114,890 |
| 2021-06-04 | Alexander Robert (Chief Executive Officer) | Option Ex | 14,516 | .69 | 9,987 |
| 2021-06-04 | Rasmussen Henrik S Md (Chief Medical Officer) | Sale | 2,435 | 89.60 | 218,176 |
| 2021-06-03 | Alexander Robert (Chief Executive Officer) | Sale | 20,001 | 92.11 | 1,842,392 |
| 2021-06-03 | Alexander Robert (Chief Executive Officer) | Option Ex | 14,517 | .69 | 9,987 |
| 2021-06-02 | Alexander Robert (Chief Executive Officer) | Sale | 20,001 | 94.56 | 1,891,194 |
| 2021-06-02 | Alexander Robert (Chief Executive Officer) | Option Ex | 14,517 | .69 | 9,987 |
| 2021-05-12 | Tomasi Adam (President and COO) | Sale | 20,000 | 99.23 | 1,984,600 |
| 2021-05-12 | Tomasi Adam (President and COO) | Option Ex | 20,000 | .69 | 13,759 |
| 2021-05-11 | Tomasi Adam (President and COO) | Sale | 20,000 | 97.79 | 1,955,800 |
| 2021-05-11 | Tomasi Adam (President and COO) | Option Ex | 20,000 | .69 | 13,759 |
| 2021-05-10 | Tomasi Adam (President and COO) | Sale | 20,000 | 96.02 | 1,920,400 |
| 2021-05-10 | Tomasi Adam (President and COO) | Option Ex | 20,000 | .69 | 13,759 |
| 2021-04-14 | Tomasi Adam (President, COO and CFO) | Sale | 20,000 | 107.77 | 2,155,400 |
| 2021-04-14 | Tomasi Adam (President, COO and CFO) | Option Ex | 20,000 | .69 | 13,759 |
| 2021-04-13 | Tomasi Adam (President, COO and CFO) | Sale | 20,000 | 103.08 | 2,061,600 |
| 2021-04-13 | Tomasi Adam (President, COO and CFO) | Option Ex | 20,000 | .69 | 13,759 |
| 2021-04-12 | Tomasi Adam (President, COO and CFO) | Sale | 20,000 | 104.40 | 2,088,000 |
| 2021-04-12 | Tomasi Adam (President, COO and CFO) | Option Ex | 20,000 | .69 | 13,759 |
| 2021-04-06 | Rasmussen Henrik S Md (Chief Medical Officer) | Sale | 10,000 | 111.68 | 1,116,800 |
| 2021-04-06 | Rasmussen Henrik S Md (Chief Medical Officer) | Option Ex | 10,000 | 1.16 | 11,630 |
| 2021-04-05 | Rasmussen Henrik S Md (Chief Medical Officer) | Sale | 20,000 | 113.06 | 2,261,200 |
| 2021-04-05 | Rasmussen Henrik S Md (Chief Medical Officer) | Option Ex | 20,000 | 1.16 | 23,260 |
| 2021-04-01 | Rasmussen Henrik S Md (Chief Medical Officer) | Sale | 20,000 | 114.40 | 2,288,000 |
| 2021-04-01 | Rasmussen Henrik S Md (Chief Medical Officer) | Option Ex | 20,000 | 1.16 | 23,260 |
| 2021-03-26 | Mckearn John P (Director) | Sale | 7,439 | 115.00 | 855,485 |
| 2021-03-26 | Janney Daniel (Director) | Sale | 17,308 | 115.55 | 1,999,939 |
| 2021-03-22 | Janney Daniel (Director) | Sale | 13,148 | 119.84 | 1,575,656 |
| 2021-03-17 | Alexander Robert (Chief Executive Officer) | Sale | 20,000 | 121.14 | 2,422,800 |
| 2021-03-17 | Alexander Robert (Chief Executive Officer) | Option Ex | 20,000 | .69 | 13,759 |
| 2021-03-16 | Alexander Robert (Chief Executive Officer) | Sale | 20,000 | 121.76 | 2,435,200 |
| 2021-03-16 | Alexander Robert (Chief Executive Officer) | Option Ex | 20,000 | .69 | 13,759 |
| 2021-03-16 | James Steven P (Director) | Sale | 3,500 | 121.65 | 425,775 |
| 2021-03-16 | James Steven P (Director) | Option Ex | 3,500 | .53 | 1,837 |
| 2021-03-15 | Alexander Robert (Chief Executive Officer) | Sale | 20,000 | 122.78 | 2,455,600 |
| 2021-03-15 | Alexander Robert (Chief Executive Officer) | Option Ex | 20,000 | .69 | 13,759 |
| 2021-03-15 | Janney Daniel (Director) | Sale | 6,708 | 124.56 | 835,548 |
| 2021-03-12 | Janney Daniel (Director) | Sale | 4,071 | 124.18 | 505,536 |
| 2021-03-11 | Hudson Peter A (Other) | Sale | 20,247 | 124.32 | 2,517,167 |
| 2021-03-11 | Janney Daniel (Director) | Sale | 6,006 | 124.62 | 748,467 |
| 2021-03-10 | Hudson Peter A (Other) | Sale | 2,107 | 124.37 | 262,047 |
| 2021-03-10 | Tomasi Adam (President, COO and CFO) | Sale | 20,000 | 121.78 | 2,435,600 |
| 2021-03-10 | Tomasi Adam (President, COO and CFO) | Option Ex | 20,000 | .69 | 13,759 |
| 2021-03-09 | Hudson Peter A (Other) | Sale | 2,200 | 124.97 | 274,934 |
| 2021-03-09 | Tomasi Adam (President, COO and CFO) | Sale | 20,000 | 121.78 | 2,435,600 |
| 2021-03-09 | Tomasi Adam (President, COO and CFO) | Option Ex | 20,000 | .69 | 13,759 |
| 2021-03-09 | Janney Daniel (Director) | Sale | 100 | 125.00 | 12,500 |
| 2021-03-08 | Tomasi Adam (President, COO and CFO) | Sale | 20,000 | 122.78 | 2,455,600 |
| 2021-03-08 | Tomasi Adam (President, COO and CFO) | Option Ex | 20,000 | .69 | 13,759 |
| 2021-03-05 | More Robert J (Other) | Sale | 12,676 | 118.73 | 1,505,021 |
| 2021-03-04 | More Robert J (Other) | Sale | 15,000 | 111.30 | 1,669,500 |
| 2021-03-04 | Nohra Guy P (10% Owner) | Sale | 25,768 | 111.33 | 2,868,828 |
| 2021-03-03 | Tomasi Adam (President, COO and CFO) | Sale | 3,189 | 113.56 | 362,142 |
| 2021-03-03 | Rasmussen Henrik S Md (Chief Medical Officer) | Sale | 21,952 | 112.92 | 2,478,710 |
| 2021-03-03 | Rasmussen Henrik S Md (Chief Medical Officer) | Option Ex | 20,000 | 1.16 | 23,260 |
| 2021-03-03 | More Robert J (Other) | Sale | 4,878 | 112.81 | 550,306 |
| 2021-03-02 | Rasmussen Henrik S Md (Chief Medical Officer) | Sale | 20,000 | 117.32 | 2,346,400 |
| 2021-03-02 | Rasmussen Henrik S Md (Chief Medical Officer) | Option Ex | 20,000 | 1.16 | 23,260 |
| 2021-03-01 | Rasmussen Henrik S Md (Chief Medical Officer) | Sale | 20,000 | 120.66 | 2,413,200 |
| 2021-03-01 | Rasmussen Henrik S Md (Chief Medical Officer) | Option Ex | 20,000 | 1.16 | 23,260 |
| 2020-12-31 | Walker Paul Edward (Director) | Sale | 35,023 | 140.55 | 4,922,447 |
| 2020-12-30 | Walker Paul Edward (Director) | Sale | 68,392 | 142.49 | 9,745,244 |
| 2020-12-29 | Tomasi Adam (President, COO and CFO) | Option Ex | 5,416 | 4.31 | 23,359 |
| 2020-12-29 | Alexander Robert (Chief Executive Officer) | Option Ex | 8,240 | 4.31 | 35,539 |
| 2020-06-17 | Nohra Guy P (10% Owner) | Sale | 7,692 | 76.32 | 587,053 |
| 2020-05-18 | Hudson Peter A (Other) | Sale | 11,538 | 71.73 | 827,620 |
| 2020-05-18 | More Robert J (Other) | Sale | 11,538 | 72.00 | 830,736 |
| 2020-05-12 | 3x5 Rivervest Fund Ii-b, L.p. (10% Owner) | Sale | 1,150,000 | 71.04 | 81,696,000 |
| 2020-05-12 | Mckearn John P (Director) | Sale | 1,150,000 | 71.04 | 81,696,000 |
| 2019-06-07 | 3x5 Rivervest Fund Ii-b, L.p. (10% Owner) | Sale | 38,732 | 40.42 | 1,565,431 |
| 2019-06-07 | Mckearn John P (Director) | Sale | 38,732 | 40.42 | 1,565,431 |
| 2019-06-06 | 3x5 Rivervest Fund Ii-b, L.p. (10% Owner) | Sale | 47,893 | 40.01 | 1,916,198 |
| 2019-06-06 | Mckearn John P (Director) | Sale | 47,893 | 40.01 | 1,916,198 |
| 2019-06-05 | 3x5 Rivervest Fund Ii-b, L.p. (10% Owner) | Sale | 23,748 | 39.65 | 941,608 |
| 2019-06-05 | Mckearn John P (Director) | Sale | 23,748 | 39.65 | 941,608 |
| 2019-06-04 | 3x5 Rivervest Fund Ii-b, L.p. (10% Owner) | Sale | 22,094 | 39.95 | 882,655 |
| 2019-06-04 | Mckearn John P (Director) | Sale | 22,094 | 39.95 | 882,655 |
| 2019-06-03 | 3x5 Rivervest Fund Ii-b, L.p. (10% Owner) | Sale | 28,906 | 39.59 | 1,144,301 |
| 2019-06-03 | Mckearn John P (Director) | Sale | 28,906 | 39.59 | 1,144,301 |
| 2019-05-31 | 3x5 Rivervest Fund Ii-b, L.p. (10% Owner) | Sale | 17,321 | 39.12 | 677,597 |
| 2019-05-31 | Mckearn John P (Director) | Sale | 17,321 | 39.12 | 677,597 |
| 2019-05-30 | 3x5 Rivervest Fund Ii-b, L.p. (10% Owner) | Sale | 7,679 | 41.66 | 319,945 |
| 2019-05-30 | Mckearn John P (Director) | Sale | 7,679 | 41.66 | 319,945 |
| 2019-04-18 | 3x5 Rivervest Fund Ii-b, L.p. (10% Owner) | Sale | 3,428 | 35.45 | 121,505 |
| 2019-04-18 | Mckearn John P (Director) | Sale | 3,428 | 35.45 | 121,505 |
| 2019-04-17 | 3x5 Rivervest Fund Ii-b, L.p. (10% Owner) | Sale | 55,889 | 36.02 | 2,012,842 |
| 2019-04-17 | Mckearn John P (Director) | Sale | 55,889 | 36.33 | 2,030,447 |
| 2019-04-16 | 3x5 Rivervest Fund Ii-b, L.p. (10% Owner) | Sale | 30,000 | 37.02 | 1,110,450 |
| 2019-04-16 | Mckearn John P (Director) | Sale | 30,000 | 37.02 | 1,110,450 |
| 2019-02-19 | 3x5 Rivervest Fund Ii-b, L.p. (10% Owner) | Sale | 92,219 | 34.34 | 3,166,800 |
| 2019-02-19 | Mckearn John P (Director) | Sale | 92,219 | 34.34 | 3,166,800 |
| 2019-02-15 | 3x5 Rivervest Fund Ii-b, L.p. (10% Owner) | Sale | 50,000 | 34.88 | 1,743,750 |
| 2019-02-15 | Mckearn John P (Director) | Sale | 50,000 | 34.88 | 1,743,750 |
| 2019-01-24 | Mckearn John P (Director) | Sale | 52,837 | 42.84 | 2,263,537 |
| 2018-07-23 | Mckearn John P (Director) | Buy | 111,111 | 18.00 | 1,999,998 |
| 2018-07-23 | Nohra Guy P (10% Owner) | Buy | 250,000 | 18.00 | 4,500,000 |
| 2018-07-23 | Janney Daniel (Director) | Buy | 250,000 | 18.00 | 4,500,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of ALLK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Allakos Inc. (symbol ALLK, CIK number 1564824) see the Securities and Exchange Commission (SEC) website.